Keywords: Pregnancy; rubella; varicella-zoster; hepatitis B; vaccination; anti-HBs; hepatitis B surface antibody; CDC; Centers for Disease Control and Prevention; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HCW; health care worker; MSSS; Ministèr
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Immunization program; Japan; Vaccine gap; Varicella vaccine; hepatitis B vaccine; Measles elimination; Human papilloma virus vaccine; Vaccine shortage; HPV; human papillomavirus; NIP; National Immunization Program; VPD; vaccine-preventable diseases; WHO-W
Keywords: Lectins; Molecular farming; Monoclonal antibodies; Plant secondary metabolites; Therapeutic anti-cancer vaccines; APIs; active pharmaceutical ingredients; ADCC; antibody-dependent cellular cytotoxicity; ADCs; antibody-drug conjugates; ATPS; aqueous two-
Keywords: 5,10-CH2-THF; 5,10-methylene-tetrahydrofolate; CHX; cycloheximide; C; HCC tissues; DAPI; 4,6â²-diamidino-2-phenylindole; DCFH-DA; 2â²,7â²-Dichlorofluorescin diacetate; DMEM; Dulbecco's modified Eagle medium; ECL; enhanced chemiluminescence; EGF; epider
Keywords: Hepatitis B virus (HBV); Hepatitis C virus (HCV); Breast cancer; Chemotherapy; HBV/HCV reactivation; Toxicity; HCV; hepatitis C virus; CHC; chronic hepatitis C; HBV; hepatitis B virus; CHB; chronic hepatitis B; DAAs; direct-acting antiviral agents; ER; es
Keywords: HCC; hepatocellular carcinoma; MVI; microvascular invasion; HBsAg; hepatitis B surface antigen; ALT; alanine aminotransferase; TB; total bilirubin; ALB; serum albumin; GGT; gamma glutamyl transpeptidase; AFP; alpha-fetoprotein; PLT; platelet count; CECT;
Keywords: DTaP; Polio; Hib; Hepatitis B; Hexavalent; Vaccine; Safety; Immunogenicity; AE; adverse event(s); CI; confidence interval; D; diphtheria toxoid; DTaP5; diphtheria, tetanus, acellular pertussis (5-component) vaccine (Daptacelâ¢); DTPa3-HB-IPV/Hib; diphthe
Keywords: AMP; Agence de Médecine Préventive; DTP; diphtheria-tetanus-pertussis; EPI; Expanded Programme on Immunisation; GAVI; Global Alliance for Vaccines and Immunisation; HBV; hepatitis B virus; HBsAg; hepatitis B surface antigen; HPV; human papillomavirus; M
Keywords: APC; antigen presenting cells; CSP; circumsporozoite protein; DHF; dengue haemorrhagic fever; DSS; dengue shock syndrome; GMP; good manufacturing practices; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; HIV; human immunodeficiency virus; HPV
Keywords: ACR; acute cellular rejection; AFLP; acute fatty liver of pregnancy; BCS; Budd-Chiari syndrome; HELLP; haemolysis, elevated liver enzymes and low platelets syndrome; HEV; hepatitis E virus; HBsAg; hepatitis B surface antigen; HCV; hepatitis C virus; HG; h
Keywords: HCC; Hepatocellular carcinoma; HBV; Hepatitis B virus; HBSAg; Hepatitis B surface antigen; HCV; Hepatitis C virus; HIV; Human immunodeficiency virus; Immigration; Viral hepatitis; Cirrhosis;
Keywords: AFP; alpha fetoprotein; HBsAg; hepatitis B surface antigen; HCC; hepatocellular carcinoma; TTP; time to progression;
Keywords: adalimumab; biologics; etanercept; infliximab; monitoring; psoriasis; psoriatic arthritis; safety; screening; ustekinumab; AAD; American Academy of Dermatology; ALP; alkaline phosphatase; ALT; alanine transaminase; ANA; antinuclear antibody; AST; aspartat
Keywords: APC; professional antigen presenting cell; bGal; beta-galactosidase; CD; cluster of differentiation; CpG; CpG oligodeoxynucleotides; CT; cholera toxin; CTL; cytotoxic T cell; CSSS; cyanoacrylate skin surface stripping; dDC; dermal dendritic cell; DNA; deo
Keywords: Hepatitis B; Guidelines; Antiviral Therapy; Peginterferon alfa-2a; Entecavir; Tenofovir; Resistance; AFP; alpha-fetoprotein; ALT; alanine aminotransferase; anti-HBc; antibody to hepatitis B core antigen; anti-HBe; antibody to hepatitis B e antigen; anti-H
Keywords: HCC; hepatocellular carcinoma; HBV; hepatitis B virus; HCV; hepatitis C virus; HBsAg; hepatitis B surface antigen; anti-HCV; antibodies against hepatitis C virus; MDS; mediterranean diet score; OR; odds ratio; CI; confidence interval; BMI; body mass index
Keywords: HBV; hepatitis B virus; HDV; hepatitis delta/D virus; HDAg; hepatitis delta antigen; L-HDAg; large hepatitis delta antigen; HBsAg; hepatitis B surface antigen; Hepatitis delta virus; Molecular epidemiology; Western Pacific region; Oceania; Genotype; Afric
Keywords: AFB1; aflatoxin B1; OTA; ochratoxin A; LB; lower bound; MB; medium bound; UB; upper bound; HCC; hepato cellular carcinoma; BW; body weight; TDI; tolerable daily intake; PTDI; provisional tolerable daily intake; PMTDI; provisional maximum tolerable daily i
Keywords: AMD; age-related macular degeneration; BMI; body mass index; CI; confidence interval; GA; geographic atrophy; HBsAg; hepatitis B surface antigen; HDL; high-density lipoprotein; KNHANES; Korea National Health and Nutrition Examination Survey; LRA; logistic
Keywords: ALT; alanine aminotransferase; CHBe-; HBeAg-negative chronic hepatitis B; CHBe+; HBeAg-positive chronic hepatitis B; CHD; chronic hepatitis D; CI; confidence interval; HBeAg; hepatitis B “e” antigen; HBsAg; hepatitis B surface antigen; HBV DNA; hepati
Keywords: Ad; adenovirus; rAd; recombinant adenovirus; WT; wild-type; E1; early region 1; E4; early region 4; HBsAg; hepatitis B virus surface antigen; hr404; host range mutation in DNA binding protein; rAd5hr; recombinant Ad 5 with hr404 mutation; Ad5hrSIVenv/rev;
Keywords: FRAP; ferric reducing antioxidant power; FBS; fetal bovine serum; GAE; gallic acid equivalents; GSE; grape seed extract; HBeAg; hepatitis B “e” antigen; HBsAg; hepatitis B surface antigen; HCC; hepatocellular carcinoma; HBV; human hepatitis B; MAPK; m
Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAgâ) on anti-TNF therapy have a low rate of reactivation
Keywords: IMID; immune-mediated inflammatory diseases; anti-HBc; antibody to hepatitis B core antigen; HBsAg; hepatitis B surface antigen; IBD; inflammatory bowel disease; TB; tuberculosis; HBV; hepatitis B virus; RA; rheumatoid arthritis; AGA; American Gastroenter
Performance of the cobas Hepatitis B virus (HBV) test using the cobas 4800 system and comparison of HBV DNA quantification ability between the COBAS AmpliPrep/COBAS TaqMan HBV test version 2.0 and cobas HBV test
Keywords: Anti-HBc Ab; hepatitis B core antibodies; CAP/CTM v2.0; COBAS AmpliPrep/COBAS TaqMan HBV version 2.0; CI; confidence interval; HBsAg; Hepatitis B surface antigen; HBV; hepatitis B virus; LOD; limit of detection; Cobas HBV test; Hepatitis B virus; DNA quan
Heteroassembled gold nanoparticles with sandwich-immunoassay LSPR chip format for rapid and sensitive detection of hepatitis B virus surface antigen (HBsAg)
Keywords: Heteroassembled AuNPs; Sandwich-immunoassay; LSPR chip format; Hepatitis B virus; HBsAg;
Gamma-glutamyl transpeptidase-to-platelet ratio predicts the prognosis in HBV-associated acute-on-chronic liver failure
Keywords: HBV; hepatitis B virus; ACLF; acute-on-chronic liver failure; LC; liver cirrhosis; CHB; chronic hepatitis B; HBsAg; hepatitis B surface antigen; HBeAg; hepatitis B e antigen; GPR; gamma-glutamyl transpeptidase-to-platelet ratio; MELD; model for end-stage
miR-146 promotes HBV replication and expression by targeting ZEB2
Keywords: HBV; hepatitis B virus; HCC; hepatocellular carcinoma; ZEB2; Zinc finger E-box-binding homeobox 2; IFN-α; interferon-α; NA; nucleotide analogues; miRNAs; microRNAs; CHB; chronic hepatitis B; CHORDC1; cysteine- and histidine-rich domain containing 1; FBS
Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses
Keywords: Hepatitis B virus; Yeast-derived recombinant vaccine; Immunogenicity; Lymphocyte subsets; Vaccine failure; HBV; hepatitis B virus; HBIG; hepatitis B immunoglobulin; HBsAg; hepatitis B surface antigen; HBeAg; hepatitis B e antigen; anti-HBc; antibodies aga
Silica-encapsulated quantum dots for highly efficient and stable fluorescence immunoassay of C-reactive protein
Keywords: Ab; antibody; Ag; antigen; BS; buffersodium borate buffer; BSA; bovine serum albumin; CB buffer; carbonate-bicarbonate buffer; CRP; C-reactive protein; DLS; dynamic light scattering; ELISA; enzyme-linked immunosorbent assay; EDC; 1-ethyl-3-(3-(dimethylami
Immunoprophylaxis Failure of Infants Born to Hepatitis B Carrier Mothers Following Routine Vaccination
Keywords: CI; confidence interval; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; IF; immunoprophylaxis failure;
Frequency of hepatitis B surface antigen variants (HBsAg) in hepatitis B virus genotype B and C infected East- and Southeast Asian patients: Detection by the Elecsys® HBsAg II assay
Keywords: HBsAg; hepatitis B surface antigen; HBV; hepatitis B virus; MHR; major hydrophilic region; Hepatitis B; HBsAg mutations; Detection; Screening; Immunoassay; Immunodominant 'a' determinant region;
Sequence analysis of sub-genotype D hepatitis B surface antigens isolated from Jeddah, Saudi Arabia
Keywords: HBV; hepatitis B virus; HAV; hepatitis A virus; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; P; HBV polymerase gene; C/pre C; HBV core/pre Core gene; X; HBV X gene; HBsAg; HBV surface antigen; IFN; interferon; Pre S1/Pre S2/S; HBsAg genes; PCR;
Epigenome-wide study for the offspring exposed to maternal HBV infection during pregnancy, a pilot study
Keywords: BMI; Body mass index; HBsAg; Hepatitis B Surface Antigen; HBxAg; Hepatitis B x antigens; RUV; Removal Unwanted Variation; DNA methylation; Human methylation 450 Beadchip; Prenatal HBV infection;
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
Keywords: Hepatitis B virus; HBsAg; Immune response; TLR7;
HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element
Keywords: Hepatitis B virus; HBsAg; Posttranscriptional regulatory element; Dihydroquinolizinone; RNA degradation; AAV; adeno-associated virus; ACT-D; actinomycin-D; cccDNA; covalently closed circular DNA; CHX; cycloheximide; DHBV; duck hepatitis B virus; DHQ; dihy
Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen
Keywords: Chitosan; β-glucan; HBsAg; Polymeric particles; Vaccine adjuvants;
Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver
Keywords: PRR; Virus Immune Evasion; PAMP; Ex Vivo; CHB; chronic hepatitis B; CTRL; uninfected control; dsRNA; double-stranded RNA; HBcAg; HBV core protein; HBeAg; hepatitis B e antigen; HBsAg; HBV surface protein; HBV; hepatitis B virus; IFN; interferon; ISG; in
Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients
Keywords: Viral Hepatitis; Immune Regulation; Neutralizing Antibody Response; Immunotherapy; ADCC; antibody-dependent cell-mediated cytotoxicity; anti-HBs; antibodies specific for hepatitis B surface antigen; ASC; antibody-secreting cell; CHB; chronic hepatitis B;
Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana
Keywords: Linfoma no hodgkiniano; Linfoma de Hodgkin; VIH; Sida; Tratamiento antirretroviral; Non-Hodgkin's lymphoma; Hodgkin's lymphoma; HIV; AIDS; Antiretroviral therapy; ABC; abacavir; ABVD; adriamicina, bleomicina, vinblastina y dacarbazina; Ara-C; arabinósido
Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes
Keywords: CC; column chromatography; ECD; electronic circular dichroism; HBeAg; HBV e antigen; HBsAg; HBV surface antigen; HBV; hepatitis B virus; HPLC; high performance liquid chromatography; MPLC; medium pressure liquid chromatography; MS; mass spectrum; NMR; nuc
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapy
Keywords: cccDNA; Chronic hepatitis B; HBcrAg; HBsAg; Hepatitis B core-related antigen; Hepatitis B virus; Pegylated interferon; Predictor; Stopping rule; Treatment response;
An ultra-sensitive Abbott ARCHITECT® assay for the detection of hepatitis B virus surface antigen (HBsAg)
Keywords: HBsAg; HBsAg mutants; HBV genotypes; Immunoassay; Nucleic acid test (NAT);
Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection
Keywords: Vaccine; HBsAg; Nanogels; Chitosan; Poly-γ-glutamic acid;
A simple and versatile paper-based electrochemiluminescence biosensing platform for hepatitis B virus surface antigen detection
Keywords: Paper-based biosensor; Electrochemiluminescence; Sandwich immunoassay; Detection; HBsAg;
Exosomes as adjuvants for the recombinant hepatitis B antigen: First report
Keywords: Exosomes; Extracellular vesicles; HBsAg; Poly-ε-caprolactone/chitosan nanoparticles; Vaccine adjuvant;
Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners
Keywords: HBV cccDNA; Transcription factor; Epigenetic regulation; ZHX2; Zinc finger and homeoboxes 2; HBV; hepatitis B virus; cccDNA; covalently closed circular DNA; HBeAg; hepatitis B e antigen; HBsAg; hepatitis B surface antigen; HBcAg; hepatitis B core antigen;
Impact of hepatitis B virus (HBV) infection on platelet response to clopidogrel in patients undergoing coronary stent implantation
Keywords: HBsAg; Hepatitis B surface antigen; CLR; clopidogrel low response; SNP; single nucleotide polymorphism; PLADP; platelet aggregation in response to 5â¯Î¼mol/L adenosine diphosphate; PLAA; platelet aggregation in response to 1â¯mmol/L arachidonic acid; EM
The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA
Keywords: CHB; chronic hepatitis B; HBV; hepatitis B virus; NA; nucleos(t)ide analogue; cccDNA; covalently closed circular DNA; guide RNA; gRNA; NTCP; sodium taurocholate cotransporting polypeptide; RC-DNA; relaxed circular DNA; pgRNA; pregenomic RNAs; HBsAg; HBV s
Activity of nucleic acid polymers in rodent models of HBV infection
Keywords: Nucleic acid polymer; HBV; HBsAg; Woodchuck; Mouse;
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
Keywords: Immune Regulation; Clinical Trial; T-Cell Inhibition; Viral Hepatitis Treatment; 7-AAD; 7-amino-actinomycin D; CHB; chronic hepatitis B; HBsAg; hepatitis B surface antigen; HBV; hepatitis BÂ virus; IFN; interferon; IL; interleukin; NK; natural killer; NUC